Works by Guo, Yingying


Results: 157
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    P636: A FIRST‐IN‐HUMAN PHASE 1 STUDY OF ORAL LOXO‐338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969448.21678.5f
    By:
    • Kwiatek, Michal;
    • Subramanian Guru Murthy, Guru;
    • Hoffmann, Marc;
    • Roeker, Lindsey;
    • Tessoulin, Benoit;
    • Danilov, Alexey;
    • Alencar, Alvaro J.;
    • Shah, Nirav N.;
    • Ghesquieres, Herve;
    • Le Gouill, Steven;
    • Jurczak, Wojciech;
    • R. Mato, Anthony;
    • Patel, Vishalkumar;
    • Guo‐Avrutin, Yingying;
    • Pauff, James M.;
    • Kazmierczak, Maciej
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.

    Published in:
    Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 865, doi. 10.1002/cpt.1183
    By:
    • Hoeben, Eef;
    • Chen, Dapeng;
    • Hartmann, Georgy;
    • Menzel, Karsten;
    • Guo, Yingying;
    • Sugiyama, Yuichi;
    • Unadkat, Jashvant D.;
    • Galetin, Aleksandra;
    • Chu, Xiaoyan;
    • Tatosian, Daniel;
    • Parrott, Neil J.;
    • Brouwer, Kim L.R.;
    • Hsu, Vicky;
    • Huang, Shiew‐Mei;
    • Nagar, Swati;
    • Matsson, Pär;
    • Sharma, Pradeep;
    • Snoeys, Jan
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50